Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 971 to 980 of 2573

TitleReference numberPublishedLast updated
Filgotinib for treating moderate to severe rheumatoid arthritisTA676
Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal)TA674
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)TA675
PROPEL sinus implants for maintaining sinus patency after surgeryMIB253
moorLDLS-BI for burn depth assessmentMIB251
The STAK tool for preventing and treating knee stiffnessMIB252
Trabectedin for the treatment of advanced soft tissue sarcomaTA185
URO17 for detecting bladder cancerMIB250
Leukomed Sorbact for preventing surgical site infectionHTG567
Mepolizumab for treating severe eosinophilic asthmaTA671

Results per page

  1. 10
  2. 25
  3. 50
  4. All